Associations with M. genitalium infection
| MG positive n (%) | MG negative n (%) | OR (95% CI) | P value | |
| Age group (years) | 0.9 (0.7 to 1.2) | 0.4261 | ||
| ≤29 | 34 (13.4) | 219 (86.6) | 0.2 (0.1 to 0.2) | |
| 30–39 | 20 (14.1) | 122 (85.9) | 0.2 (0.1 to 0.3) | |
| 40–49 | 12 (19.4) | 50 (80.7) | 0.2 (0.1 to 0.5) | |
| ≥50 | 2 (3.9) | 49 (96.1) | 0.0 (0.0 to 0.2) | |
| On PrEP | 2.1 (1.3 to 3.6) | 0.0041 | ||
| Yes | 33/169 (19.5) | 136/169 (80.5) | ||
| No | 35/339 (10.3) | 304/339 (89.7) | ||
| Anorectal CT | 3.9 (1.8 to 8.5) | 0.0002 | ||
| Yes | 11/45 (24.4) | 35/460 (7.6) | ||
| No | 34/45 (75.6) | 425/460 (92.4) | ||
| Anorectal NG | 1.5 (0.5 to 4.3) | 0.5036 | ||
| Yes | 4/45 (8.9) | 29/460 (6.3) | ||
| No | 41/45 (91.1) | 431/460 (93.7) | ||
| Urethral CT | 2.2 (0.5 to 10.2) | 0.2902 | ||
| Yes | 2/24 (8.3) | 19/484 (3.9) | ||
| No | 22/24 (91.7) | 465/484 (96.1) | ||
| Urethral NG | 3.0 (0.4 to 25.2) | 0.2966 | ||
| Yes | 1/24 (4.2) | 7/484 (1.5) | ||
| No | 23/24 (95.8) | 477/484 (98.6) | ||
| Male partners last 3/12 | 1.2 (0.9 to 1.5) | 0.30 | ||
| 0 | 1/8 (12.5) | 7/8 (87.5) | 0.1 | |
| 1 | 12/86 (14.0) | 74/86 (86.1) | 0.2 | |
| 2–5 | 29/252 (11.5) | 223/252 (88.5) | 0.1 | |
| 6–10 | 16/96 (16.7) | 80/96 (83.3) | 0.2 | |
| >10 | 10/57 (17.5) | 47/57 (82.5) | 0.2 | |
| Female partners last 3/12 | 1.8 (0.8 to 4.2) | 0.1511 | ||
| Yes | 8/68 (11.8) | 30/439 (6.8) | ||
| No | 60/68 (88.2) | 409/439 (93.2) | ||
| Condom use | 0.8 (0.6 to 1.0) | 0.0186 | ||
| Never | 16/94 (17.0) | 78/94 (83.0) | 0.2 | |
| <50% | 19/117 (16.2) | 98/117 (83.8) | 0.2 | |
| ≥50% | 24/168 (14.3) | 144/168 (85.7) | 0.2 | |
| Always | 7/108 (6.5) | 101/108 (93.5) | 0.1 | |
| N/A | 1/15 (6.7) | 14/15 (93.3) | 0.1 | |
| HIV infection | 0.7 (0.2 to 2.4) | 0.5749 | ||
| Yes | 3/30 (10.0) | 27/30 (90.0) | ||
| No | 65/478 (13.6) | 413/478 (86.4) |
Condom use, condom use for anal sex last 3 months: N/A, no anal sex in the last 3 months (data missing for six men); female partners last 3/12, any female sexual partner/s in the last 3 months (data missing for one man); male partners last 3/12, number of male sexual partners in the last 3 months (data missing for nine men).
CT, Chlamydia trachomatis; MG, Mycoplasma genitalium; N/A, not available; NG, Neisseria gonorrhoeae; PrEP, HIV pre-exposure prophylaxis.